Replies to post #106909 on Avid Bioservices Inc (CDMO)

[mojojojo]

FDA response would be key in my opinion to the partners fighting each other to climb on board.

I don't agree. At this point PPHM and all the potential partners know what bavi has to offer. They now have the definitive results from the 2nd-line NSCLC trial in hand and also enough data from the other two phase 2 trials to know what will happen with them. If all of these trials follow suite with good results it doesn't matter what the FDA's decision is regarding the coding errors.

All IMO,

mojo